Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01708694 · ClinicalTrials.gov registry record · NA
Role of Slowly Digesible Starch on Diabetes Risk Factors
A NA study, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- NA
- Development phase
- 65
- Enrollment target
NCT01708694 is a NA study that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 65 participants.
The verdict
NCT01708694, a NA study, has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 65 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effect of a slowly digesting starch on gut bacteria, sugar and fat metabolism, hunger hormones, and body fat in people with pre-diabetes.
Interventions
- DIETARY_SUPPLEMENT Amylose
- DIETARY_SUPPLEMENT Amylopectin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2012-08 |
| Est. Completion | 2016-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01708694
The ClinicalTrials.gov registry entry for NCT01708694 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pennington Biomedical Research Center, which has 258 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Amylose is the first listed.
NCT01708694 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01708694 about?
NCT01708694 is a clinical study titled "Role of Slowly Digesible Starch on Diabetes Risk Factors". The purpose of this study is to determine the effect of a slowly digesting starch on gut bacteria, sugar and fat metabolism, hunger hormones, and body fat in people with pre-diabetes.
What is the current status of trial NCT01708694?
This trial is currently completed. It is a NA study. The enrollment target is 65 participants. The study started on 2012-08. Estimated completion is 2016-06.
What interventions are being tested in trial NCT01708694?
The interventions under investigation include: Amylose (DIETARY_SUPPLEMENT), Amylopectin (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01708694?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.